Travere Therapeutics, Inc.
Industry: Life Sciences ・ $TVTX on Nasdaq
Insider Sale
+$166,361
-5.17%
Shares
Shares Volume: 19,122 Shares
Average Share Price: $8.7
INSIDER
Dube Eric M
CHIEF EXECUTIVE OFFICER (Director)
reported on Feb 2 2024
traded on Jan 31 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 350,600 |
| PURCHASES/SALES 1Y | 0 / 4 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $121,199.38 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 7 |
| PURCHASES/SALES 1Y | 0 / 29 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $38,194.45 |
| COMPANY PREVIOUS TRADES |